SCHEMBL20726665

SCHEMBL20726665

c1cc(-c2nc(-c3cccc(-c4cc5cccnc5c5ncccc45)c3)nc(-c3ccc4oc5ccccc5c4c3)n2)cc(-c2cc3cccnc3c3ncccc23)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
NPC1 O15118 2/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
CCR1 P32246 2/20 0.40
CCR8 P51685 2/20 0.40
PDE4D Q08499 3/20 0.39
PIK3CD O00329 1/20 0.39
ALDH1A1 P00352 4/20 0.37
KDM4E B2RXH2 3/20 0.37
HPGD P15428 2/20 0.37
GAA P10253 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ALOX5 P09917 1/20 0.37
PDE4A P27815 1/20 0.36
GRM4 Q14833 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CHEK2 O96017 1/20 0.36
PLA2G10 O15496 1/20 0.36
PLA2G2A P14555 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20726663 0.93 MAPT (0.42) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL23331492 0.93 MAPT (0.46) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL20726694 0.90 PDE4D (0.39) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL15582325 0.89 MAPT (0.43) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL31285974 0.89 CCR1 (0.49) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL16697977 0.89 CCR1 (0.49) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL20726844 0.85 CCR1 (0.39) MAPTNPC1L3MBTL1CCR1CCR8
SCHEMBL20726716 0.85 CCR1 (0.45) MAPTL3MBTL1CCR1CCR8PIK3CD
SCHEMBL20726910 0.85 CCR1 (0.47) MAPTL3MBTL1CCR1CCR8PIK3CD
SCHEMBL26435249 0.85 MAPT (0.38) MAPTNPC1L3MBTL1CCR1CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3441391-B1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2020-09-02 EP disclosed
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2019-02-14 US disclosed
EP-3441391-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Display Co., Ltd. (KR) 2019-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190051841-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME AOC2, CYP1A1, CRY1 MAPT 2986/4885NPC1 3331/4885L3MBTL1 370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.